Curative Biotechnology Inc (CUBT)

[moczowy]

 IMT505 Rabies ?
(1)                   Infectious
Illnesses COVID
Vaccine with IMT504 Adjuvant COVID
19 in Kidney Failure Sufferers ?
(2)                   Oncology CUBT906-
CD56 Monoclonal Antibody ADC Glioblastoma ?
(2)                   

Degenerative

Eye
Illness

 Metformin

Reformulation Age-Associated
Macular Degeneration ?
(1)      

 

(1)Every
of those therapeutics have undergone sure toxicology and pharmacokinetics animal research.
Please see additional description in “Product Growth” under for an additional description
of the event of every indicated therapeutic.(2)Every
of those therapeutics haven’t undergone pre-clinical improvement. Please see additional description
in “Product Growth” under for an additional description of the event of
every indicated therapeutic.